Photo from wikipedia
The most common adverse event following an endoscopic retrograde cholangiopancreatography (ERCP) procedure is post‐ERCP pancreatitis (PEP). Rectal nonsteroidal anti‐inflammatory drug (NSAID) administration has shown promise to reduce the risk of… Click to show full abstract
The most common adverse event following an endoscopic retrograde cholangiopancreatography (ERCP) procedure is post‐ERCP pancreatitis (PEP). Rectal nonsteroidal anti‐inflammatory drug (NSAID) administration has shown promise to reduce the risk of PEP in high‐risk patients. However, in contrast to high‐risk patients, the role of NSAID administration in patients with low risk remains controversial.
Keywords:
risk;
ercp pancreatitis;
high risk;
risk patients;
post ercp
Journal Title: Journal of Gastroenterology and Hepatology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Gastroenterology and Hepatology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!